profile_id,first_name,last_name,sub_title,profile_picture,background_image,profile_type,entity_urn,object_urn,birth_date,summary,location,premium,influencer,treasury_media,languages,industry,education,patents,awards,certifications,organizations,projects,publications,courses,test_scores,position_groups,volunteer_experiences,skills,network_info,related_profiles,contact_info
zyfra-day,Zyfra,Day,Senior Scientist I at Charles River Laboratories,,,personal,ACoAAB4AcrQBJtimHAmwDCDYgBYsz2FvoqHLz3g,503345844,,,"{'country': 'Netherlands', 'short': 'Leiden, South Holland', 'city': 'Leiden', 'state': 'South Holland', 'default': 'Leiden, South Holland, Netherlands'}",False,False,[],"{'primary_locale': {'country': 'NL', 'language': 'nl'}, 'supported_locales': [{'country': 'NL', 'language': 'nl'}], 'profile_languages': []}",Biotechnology,"[{'date': {'start': {'month': None, 'day': None, 'year': 2013}, 'end': {'month': None, 'day': None, 'year': 2015}}, 'school': {'name': 'Wageningen University & Research', 'logo': 'https://media.licdn.com/dms/image/C510BAQFQJQXtOy2Stw/company-logo_400_400/0/1519889640020?e=1700697600&v=beta&t=DfM4gdRk76TMhZBoa5gWFhnkNZBuUm47LktavPNU9gg', 'url': 'https://www.linkedin.com/school/wageningenuniversity/'}, 'degree_name': 'Master of Science (M.Sc.)', 'field_of_study': 'Medische biotechnologie'}, {'date': {'start': {'month': None, 'day': None, 'year': 2010}, 'end': {'month': None, 'day': None, 'year': 2013}}, 'school': {'name': 'Wageningen University & Research', 'logo': 'https://media.licdn.com/dms/image/C510BAQFQJQXtOy2Stw/company-logo_400_400/0/1519889640020?e=1700697600&v=beta&t=DfM4gdRk76TMhZBoa5gWFhnkNZBuUm47LktavPNU9gg', 'url': 'https://www.linkedin.com/school/wageningenuniversity/'}, 'degree_name': 'Bachelor of Science (B.Sc.)', 'field_of_study': 'Biotechnologie'}]",[],[],[],[],[],[],[],[],"[{'company': {'id': 8306, 'name': 'Charles River Laboratories', 'logo': 'https://media.licdn.com/dms/image/D4E0BAQFaNAjaPDGgjg/company-logo_400_400/0/1688579937385?e=1700697600&v=beta&t=PKhWvA-H_MeqAQSEYs_VJ6X9VewGAr_fqXXr6bATHPQ', 'url': 'https://www.linkedin.com/company/charles-river-laboratories/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 2, 'day': None, 'year': 2017}, 'end': {'month': None, 'day': None, 'year': None}}, 'profile_positions': [{'location': 'Leiden, Zuid-Holland, Nederland', 'date': {'start': {'month': 5, 'day': None, 'year': 2023}, 'end': {'month': None, 'day': None, 'year': None}}, 'company': 'Charles River Laboratories', 'description': 'Managing client-based projects focusing on early-stage discovery using cell-based assays to identify novel targets for drug development of (rare) diseases. Combination of project management (client interaction, financial analysis, planning, and managing project team), lab-based execution of experiments (assay development, screening and target validation), data analysis, reporting, and laboratory notebook writing. Supervision/support of junior staff within project teams. Managing 2-3 projects simultaneously.\n\nTechniques:\nVirus production, virus purification, human embryonic stem cell culture, siRNA transfection, HTRF, qPCR, MSD, Western blot, High-content imaging and quantification, neuronal differentiation, transduction, PBMC isolation, T-cell based assays, Cell-Titer Glo, Real-Time Glo, immunocytochemistry staining, compound exposure, primary cell culture, suspension cell culture, FMT, use of various robotics and (semi) automated liquid handlers. Automated data analysis using Activity Base and Vortex.\n\nLean Six Sigma GreenBelt certification - ongoing\n\nPart of Works Council from March 2023 onward\n- Drafting agendas and minutes for meetings\n- Processing endorsement and advice requests\n\nMember of event planning committee from February 2019 onward:\n- Coming up with, planning and executing activities for employees\n\nCoordinator of buddy system from August 2019 onward:\n- Matching new starters with buddies to ensure warm welcome and streamline on-boarding process\n- Originated buddy system and drafted guide lines buddies share with new starters regarding procedures, general know-how, social activities, etc.', 'title': 'Senior Scientist I', 'employment_type': 'Full-time'}, {'location': 'Leiden', 'date': {'start': {'month': 2, 'day': None, 'year': 2020}, 'end': {'month': 5, 'day': None, 'year': 2023}}, 'company': 'Charles River Laboratories', 'description': 'Working in client-based projects focusing on early-stage discovery using cell-based assays to identify novel targets for drug development of (rare) diseases. Combination of lab-based execution of experiments (assay development, screening and target validation), data analysis, reporting and laboratory notebook writing, and project management-related tasks (client interaction, financial overview, planning). Supervision/support of junior staff within project teams.\n\nTechniques:\nVirus production, virus purification, human embryonic stem cell culture, siRNA transfection, HTRF, qPCR, MSD, Western blot, High-content imaging and quantification, neuronal differentiation, transduction, PBMC isolation, T-cell based assays, Cell-Titer Glo, Real-Time Glo, immunocytochemistry staining, compound exposure, primary cell culture, use of various robotics and (semi) automated liquid handlers.\n\nHead of laboratory from January 2019 onward:\n- Introducing new starters to the laboratory\n- Explaining and enforcing laboratory rules\n- General maintenance and facilities tasks\n\nMember of event planning committee from February 2019 onward:\n- Coming up with, planning and executing activities for employees\n\nCoordinator of buddy system from August 2019 onward:\n- Matching new starters with buddies to ensure warm welcome and streamline on-boarding process\n- Originated buddy system and drafted guide lines buddies share with new starters regarding procedures, general know-how, social activities, etc.', 'title': 'Scientist', 'employment_type': None}, {'location': 'Leiden', 'date': {'start': {'month': 2, 'day': None, 'year': 2017}, 'end': {'month': 2, 'day': None, 'year': 2020}}, 'company': 'Charles River Laboratories', 'description': 'Working in client-based projects focusing on early-stage discovery using cell-based assays to identify novel targets for drug development of (rare) diseases. Combination of lab-based execution of experiments and data analysis, reporting and laboratory notebook writing.\n\nTechniques:\nHuman embryonic stem cell culture, siRNA transfection, HTRF, qPCR, MSD, Western blot, High-content imaging and quantification, neuronal differentiation, transduction, PBMC isolation, T-cell based assays, Cell-Titer Glo, Real-Time Glo, immunocytochemistry staining, compound exposure, primary cell culture, use of various robotics and (semi) automated liquid handlers\n\nHead of laboratory from January 2019 onward:\n- Introducing new starters to the laboratory\n- Explaining and enforcing laboratory rules\n- General maintenance and facilities tasks\n\nMember of event planning committee from February 2019 onward:\n- Coming up with, planning and executing activities for employees', 'title': 'Associate Scientist', 'employment_type': None}]}, {'company': {'id': 1204, 'name': 'The Janssen Pharmaceutical Companies of Johnson & Johnson', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQG0V9OOxXc2sQ/company-logo_400_400/0/1519855865090?e=1700697600&v=beta&t=kBkEhJUQ2dthGwz5dyQsIpCSinixVur3vu1RAv6PZfE', 'url': 'https://www.linkedin.com/company/janssen-pharmaceutical-companies-of-johnson-and-johnson/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 7, 'day': None, 'year': 2016}, 'end': {'month': 1, 'day': None, 'year': 2017}}, 'profile_positions': [{'location': 'Leiden', 'date': {'start': {'month': 7, 'day': None, 'year': 2016}, 'end': {'month': 1, 'day': None, 'year': 2017}}, 'company': 'The Janssen Pharmaceutical Companies of Johnson & Johnson', 'description': 'Responsible for bridging study between two metabolite analysers. Writing study plans, performing experimental work, analysing and documenting data in study report. \nSampling of bioreactors to monitor metabolite concentrations, cell count, pH, and osmolality during cell and virus production runs.\nShaker flask experiments for process characterization.\nContinuous improvement, lean, 5S.\n\nTechniques: ViCell cell counts, NOVA Bioprofile 400 metabolite analysis, CuBiAn metabolite analysis, bioreactor sampling, shaker flask medium refreshment, adenovirus sample preparation, aseptic techniques.', 'title': 'Associate scientist USP', 'employment_type': None}]}, {'company': {'id': None, 'name': 'Abbott Biologicals B.V', 'logo': None, 'url': None, 'employees': {'start': None, 'end': None}}, 'date': {'start': {'month': 11, 'day': None, 'year': 2015}, 'end': {'month': 6, 'day': None, 'year': 2016}}, 'profile_positions': [{'location': 'Weesp', 'date': {'start': {'month': 11, 'day': None, 'year': 2015}, 'end': {'month': 6, 'day': None, 'year': 2016}}, 'company': 'Abbott Biologicals B.V', 'description': 'Determination of haemagglutinin (HA) content of influenza vaccine samples using the single radial diffusion (SRD) test.\nInvolvement in continuous improvement projects.\nWorking under GMP/GDP conditions.\nResult recording in SAP.', 'title': 'Quality control technician', 'employment_type': None}]}, {'company': {'id': 1204, 'name': 'The Janssen Pharmaceutical Companies of Johnson & Johnson', 'logo': 'https://media.licdn.com/dms/image/C4D0BAQG0V9OOxXc2sQ/company-logo_400_400/0/1519855865090?e=1700697600&v=beta&t=kBkEhJUQ2dthGwz5dyQsIpCSinixVur3vu1RAv6PZfE', 'url': 'https://www.linkedin.com/company/janssen-pharmaceutical-companies-of-johnson-and-johnson/', 'employees': {'start': 10001, 'end': None}}, 'date': {'start': {'month': 4, 'day': None, 'year': 2015}, 'end': {'month': 9, 'day': None, 'year': 2015}}, 'profile_positions': [{'location': 'Leiden', 'date': {'start': {'month': 4, 'day': None, 'year': 2015}, 'end': {'month': 9, 'day': None, 'year': 2015}}, 'company': 'The Janssen Pharmaceutical Companies of Johnson & Johnson', 'description': 'Internship at the department Viral Vaccines, Vector Generation. Grade: 8.0.\nExamination of the effect of different parameters on the ratio between viral particles and infectious units of type D adenovirus. \nMeasurement of transgene expression after determination of type D adenovirus infectious units with TCID50 assay.\n\t\nTechniques: TCID50 assay, mammalian cell culture, luciferase assay.', 'title': 'Intern', 'employment_type': None}]}]",[],[],,,
